[Progress and prospects on liver support therapy for liver failure]

Area of Science:

• Hepatology
• Biomedical Engineering
• Clinical Medicine

Background:

• Organ support therapies for liver failure have advanced, focusing on clearing bile acids, blood ammonia, and inflammatory factors.
• Despite progress, high-level evidence-based medicine supporting these therapies is limited.
• Understanding the pathogenesis of major liver failure subtypes is crucial.

Purpose of the Study:

• To highlight the need for extensive research on the pathogenesis of major liver failure subtypes.
• To explore collaborative key points for clinical research design decisions.
• To guide the development of appropriate organ support therapies.

Main Methods:

• This study is a review and synthesis of current research trends.
• It emphasizes the need for future clinical trials and observational studies.
• Focus is on identifying critical research gaps in liver failure management.

Main Results:

• Current organ support therapies show promise in managing specific aspects of liver failure.
• A significant gap exists in high-level evidence supporting these interventions.
• Pathogenesis research for liver failure subtypes is underdeveloped.

Conclusions:

• Extensive research into liver failure pathogenesis is necessary.
• Collaborative clinical research design is essential for advancing organ support therapy.
• Evidence-based strategies are required for optimal liver failure treatment.